Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Holdings Raised by Blue Trust Inc.

Blue Trust Inc. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 69.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 842 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Blue Trust Inc.’s holdings in Acadia Healthcare were worth $33,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC grew its position in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after purchasing an additional 454 shares during the last quarter. Covestor Ltd grew its stake in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new stake in Acadia Healthcare in the third quarter worth $86,000.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $41.96 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $3.90 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 1.75 and a beta of 1.30. The stock has a fifty day moving average of $42.10 and a 200-day moving average of $54.75. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ACHC. TD Cowen lowered their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a research report on Tuesday, January 7th. Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.